Bio Essence Corp
corporate_fare Company Profile
Bio Essence Corp (OTC:BIOE) is a publicly traded company in the Life Sciences sector. Wiseek monitors BIOE SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Bio Essence Finalizes MediFlow AI Acquisition, Issues 7M Shares at $0.50
- Q1 Profit Turnaround Amidst Going Concern, Dilutive Offerings, and Control Weaknesses
- Bio Essence Corp Acquires MediFlow AI Software for $3.5M in Stock, Signaling Strategic Shift
- Bio Essence Corp Discloses Going Concern Doubt, Ineffective Internal Controls, and $1.5M Lawsuit in Annual Report
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$1.9M
Net Income
$896.2K
Op. Cash Flow
$1.57M
Gross Profit
$1.43M
Operating Income
$900.01K
Debt / Equity
0.00×
Net Margin
47.2%
Shares Outstanding
38.01M sh
Source: 10-K · filed 2026-03-27 · accession 0001213900-26-035467
show_chartPrice Chart
Loading chart...
feed BIOE - Latest Insights
BIOE
May 19, 2026, 4:01 PM EDT
Price at Filing:
$0.300
Real-time Price:
$0.2525
Change:
-$0.0475 (-16%)
Market Cap:
N/A
BIOE
May 15, 2026, 2:09 PM EDT
Price at Filing:
$0.380
Real-time Price:
$0.2525
Change:
-$0.1275 (-34%)
Market Cap:
N/A
BIOE
Apr 23, 2026, 8:28 PM EDT
Price at Filing:
$0.450
Real-time Price:
$0.2525
Change:
-$0.1975 (-44%)
Market Cap:
N/A
BIOE
Mar 27, 2026, 3:44 PM EDT
Price at Filing:
$0.170
Real-time Price:
$0.2525
Change:
+$0.0825 (+49%)
Market Cap:
N/A